Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...

The pathogen C. diff — the most common cause of health care-associated infectious diarrhea — can use a compound that kills ...

Researchers have used genetic tools to investigate how specific nerve cells in the brain respond after a spinal cord injury.

One of the surprises in Tuesday’s long-awaited Brisbane 2032 Olympic and Paralympic Games announcement is another outdoor arena not recommended in the review.

The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...

ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...

RNAi -- functions specifically to silence, or deactivate, genes. Among other applications, it promises to be groundbreaking ...

Cibc World Markets Corp bought a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the fourth quarter, ...

An Italian research team has found that radicchio seedlings grown in a lab-scale greenhouse with a perovskite solar PV roof ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

Weissman was jointly awarded the 2023 Nobel Prize in Medicine with Katalin Karikó for discoveries which made COVID-19 ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the ...